Abstract

BackgroundLassa fever, killing thousands of people annually, is the most reported viral zoonotic disease in Nigeria. Recently, different rodent species carrying diverse lineages of the Lassa virus (LASV) in addition to a novel Mobala-like genetic sequence were detected within the country. Here, screening 906 small mammal specimens from 11 localities for IgG antibodies and incorporating previous PCR detection data involving the same populations, we further describe arenavirus prevalence across Nigeria in relation to host species and geographical location.MethodsSmall mammals were trapped during the period 2011–2015 according to geographical location (endemic and non-endemic zones for Lassa fever), season (rainy and dry seasons between 2011 and 2012 for certain localities) and habitat (indoors, peridomestic settings and sylvatic vegetation). Identification of animal specimens from genera such as Mastomys and Mus (Nannomys) was assisted by DNA sequencing. Small mammals were tested for LASV IgG antibody using an indirect immunofluorescence assay (IFA).ResultsSmall mammals were infected in both the endemic and non-endemic zones for Lassa fever, with a wider range of species IgG-positive (n = 8) than those which had been previously detected to be PCR-positive (n = 3). IgG-positive species, according to number of infected individuals, were Mastomys natalensis (n = 40), Mastomys erythroleucus (n = 15), Praomys daltoni (n = 6), Mus baoulei (n = 5), Rattus rattus (n = 2), Crocidura spp. (n = 2), Mus minutoides (n = 1) and Praomys misonnei (n = 1). Multimammate mice (Mastomys natalensis and M. erythroleucus) were the most ubiquitously infected, with animals testing positive by either PCR or IgG in 7 out of the 11 localities sampled. IgG prevalence in M. natalensis ranged from 1% in Abagboro, 17–36 % in Eguare Egoro, Ekpoma and Ngel Nyaki, up to 52 % in Mayo Ranewo. Prevalence according to locality, season and age was not, however, statistically significant for M. natalensis in Eguare Egoro and Ekpoma, localities that were sampled longitudinally.ConclusionsOverall, our study demonstrates that arenavirus occurrence is probably more widely distributed geographically and in extent of host taxa than is currently realized. This expanded scope should be taken into consideration in Lassa fever control efforts. Further sampling should also be carried out to isolate and characterize potential arenaviruses present in small mammal populations we found to be seropositive.

Highlights

  • Lassa fever, killing thousands of people annually, is the most reported viral zoonotic disease in Nigeria

  • The deadly Lassa fever in West Africa, with up to 5000 fatalities annually [1], is caused by Lassa virus (LASV) which was recently discovered to be maintained by multiple rodent reservoirs [2]

  • Select cases of meningitis or encephalitis in several countries worldwide are caused by the lymphocytic choriomeningitis virus (LCMV), which is carried by the house mouse Mus musculus [4, 5]

Read more

Summary

Introduction

Lassa fever, killing thousands of people annually, is the most reported viral zoonotic disease in Nigeria. Different rodent species carrying diverse lineages of the Lassa virus (LASV) in addition to a novel Mobala-like genetic sequence were detected within the country. The deadly Lassa fever in West Africa, with up to 5000 fatalities annually [1], is caused by Lassa virus (LASV) which was recently discovered to be maintained by multiple rodent reservoirs [2]. Within the Central African Republic [6]; Kodoko virus in Mus minutoides within Guinea [7]; and Jirandogo and Natorduori viruses in Mus baoulei and Mus mattheyi, respectively, within Ghana [8]. These fast-evolving RNA viruses, though apparently non-pathogenic, are of epidemiological importance as they possess the potential to emerge in new, possibly harmful ways. Surveys are needed to evaluate the occurrence of these arenaviruses across host species and at wider geographical scales than previously sampled, such as was recently done in Tanzania, eastern Africa [10]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.